[{'Item': [], 'Id': '705866', 'AssayName': 'Inhibition of CYP2C9', 'AssayDescription': 'Title: Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A)._||_Abstract: A novel series of quinoline isoxazole BET family bromodomain inhibitors are discussed. Crystallography is used to illustrate binding modes and rationalize their SAR. One member, I-BET151 (GSK1210151A), shows good oral bioavailability in both the rat and minipig as well as demonstrating efficient suppression of bacterial induced inflammation and sepsis in a murine in vivo endotoxaemia model.', 'ReadoutCount': NoneElement(attributes={}), 'SourceNameList': ['ChEMBL'], 'ActiveSidCount': IntegerElement(9, attributes={}), 'ActivityOutcomeMethod': 'Confirmatory', 'InactiveSidCount': NoneElement(attributes={}), 'InconclusiveSidCount': NoneElement(attributes={}), 'TotalSidCount': IntegerElement(9, attributes={}), 'XRefDburlList': [], 'XRefAsurlList': [], 'ModifyDate': '2018/09/23 00:00', 'DepositDate': '2013/06/29 00:00', 'HoldUntilDate': '1/01/01 00:00', 'AID': IntegerElement(705866, attributes={}), 'TotalCidCount': NoneElement(attributes={}), 'ActiveCidCount': NoneElement(attributes={}), 'ProteinTargetList': [{'Name': 'Cytochrome P450 2C9', 'GI': IntegerElement(6686268, attributes={})}]}]
